Hybrid outsourcing solutions deliver flexibility to fit any clinical trial. In a hybrid model, one or more FSP offerings are ...

part of the PPD™ clinical research business of Thermo Fisher Scientific. “This new CorEvitas registry – our 11 th independent registry – will allow the prospective evaluation of adolescent ...

We're modestly raising our fair value estimate to $590 per share. Shares are fairly valued Thermo Fisher's PPD Acquisition Fills Last Major Gap in Its Offering to Biopharma Not only did Thermo ...

including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. Thermo Fisher said it launched a range of high-impact, innovative new products ...

CorEvitas brings Thermo Fisher Scientific registries that gather data about how approved therapies are working in the real world. The acquisition will complement PPD, the contract research ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.39 per common share, payable ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced ...

and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 ...

Broadening global laboratory services for clinical research To serve pharma and biotech customers with advanced laboratory services and leading-edge instrumentation across all phases of pharmaceutical ...